Today
CSL posts bumper profit but top-line growth to slow
The biotech giant says margin recovery at its core blood products business will enable it to produce double-digit earnings growth for the next half a decade.
Yesterday
- Exclusive
- Health insurance
Pressure for health premium overhaul in election headache for Albanese
The influential medical lobby is demanding an independent umpire to determine how high insurance premiums can rise as negotiations over the next increase begin.
Competition regulator delays $8.8b Chemist Warehouse deal approval
The ACCC is undertaking more analysis of the transaction, which would merge the pharmacy giant into Sigma Healthcare. A decision won’t be made until October.
This Month
Psychedelics as a serious investment? These billionaires think so
Australia is among the first countries to use the drugs for treating anxiety, depression and PTSD. A decision in the United States could be pivotal.
Pfizer invests $150m in Melbourne to fight superbugs
The US pharma giant says the federal government must do more to ensure Australians can access new drugs designed to fight deadly superbugs.
Ramsay tips lower earnings, hospital capex weak
Ramsay Health Care says full-year earnings will be weaker than expected as it flags writedowns on its European operations.
- Exclusive
- Healthcare
Hospitals seek right to boycott big insurers from funding talks
Catholic-operated private hospitals want a major shake-up of the way they negotiate funding deals with health insurers, in an escalation of tensions between the two sides.
ResMed says sales growth defies weight-loss fears
Chief executive Mick Farrell says he is confident the company has put to bed investor fears that weight-loss drugs will hurt sales of its sleep apnoea products.
July
Inside the stoush between private hospitals and health insurers
As finances deteriorate, insurers and providers are slugging it out over how to overhaul a healthcare system which has not seen serious reform in decades.
Telix shares hit new high on upgraded revenue forecast
The biotech’s shares double in value this year due to strong sales in the United States for its prostate cancer imaging product.
Ramsay’s French asset posts weaker earnings, launches debt refinancing
The healthcare provider says lower government subsidies and inflation are hurting the performance of its Ramsay Sante business.
April
For the full zen, stay at an ancient temple in Japan
Our writer bypasses the hotels and ryokans to spend a night as a guest of Buddhist monks. He didn’t anticipate the wooden stick, though.
- Opinion
- AUKUS
Japan’s ‘cowardly’ media fails to take on corporate giants
As he leaves Japan as the AFR’s North Asia correspondent, Michael Smith reflects on a media that is often too scared to hold its government and CEOs to account.
- Updated
In six and a half years I witnessed a dark pivot in China
When I first landed in Shanghai on a freezing winter’s night in January 2018, China felt like a place bursting with optimism and opportunity.
The man who cracked Japan’s crime gangs is back for a sequel
Jake Adelstein’s Tokyo Vice exposed Japan’s yakuza. Now he’s out of police protection and releasing a new book.
- Updated
- Crime
‘I’m loving a monster’: Cauchi’s dad speaks out
The parents of killer Joel Cauchi are “heartbroken” for victims of the Bondi attack, saying they believe their son was in a psychosis when he murdered six people.
- Updated
Red tape warning despite booming Japan-Australia deals
Japanese investment in Australia is rising, but a new report shows data is mixed, and Australia is warned about policy uncertainty and delays in approving deals.
Japan is finally waking up from its lost decades. Can it last?
The country is doing defence deals and its economy is powering up. But it has a fight on its hands to keep the momentum going given its structural challenges.
- Updated
Chinese Premier Li Qiang tipped to visit Australia in June
If confirmed, a June visit by Mr Li would follow Foreign Minister Wang Yi’s visit last month and China’s decision to lift tariffs on Australian wine.
The data that reveals the truth about Australia’s China ties
Although Australia’s relations with China have warmed, key metrics show economic ties are at their lowest levels in more than five years and are unlikely to bounce back.
